Kidney disease and patients on dialysis
M., Ricoult, S
If you pause your medication for more than a few weeks, your body may re-sensitize to semaglutide, meaning some patients experience stronger appetite-suppression effects when they resume
JAMA 322 , 21042114 (2019)
Sometimes, including a GLP-1 probiotic alongside Semaglutide or Tirzepatide can lower the side effects linked to those meds
Indeed, we can argue that the effectiveness, easy applicability, safe clinical profile and mechanism of BPC 157 (i.eBPC 157/dopamine/glutamate/NO system) represent an alternative, likely successful, future therapeutic direction for neurological conditions. Additional studies have shown that BPC 157 can offer tendon, ligament, and skeletal muscle healing (Gwyer, et al, 2019) it is apparent that BPC 157 has huge potential and following further development has promise as a therapy to conservatively treat or aid recovery in hypovascular and hypocellular soft tissues such as tendon and ligaments